Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008 Jun;52(6):2289-90.
doi: 10.1128/AAC.00299-08. Epub 2008 Mar 24.

IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico

Craig A Martin, Kazumi Morita, Julie A Ribes, Lalitagauri M Deshpande, Helio S Sader, Mariana Castanheira
Case Reports

IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico

Craig A Martin et al. Antimicrob Agents Chemother. 2008 Jun.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Schematic representation of the class 1 integrons containing blaIMP-15: (a) 6-kb integron In95 found in P. aeruginosa isolate 1750J from Lexington, KY, and also in a P. aeruginosa isolate from Guadalajara, Mexico (GenBank accession no. EF184216); (b) blaIMP-15-carrying integron found in a P. aeruginosa isolate in Thailand (GenBank accession no. AY553333). The horizontal arrows indicate the gene cassettes and their respective translation orientations. 59-be, 59-base element.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Aboufaycal, H., H. S. Sader, K. Rolston, L. M. Deshpande, M. Toleman, G. Bodey, I. Raad, and R. N. Jones. 2007. blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC Program. J. Clin. Microbiol. 45:614-5. - PMC - PubMed
    1. Hanson, N. D., A. Hossain, L. Buck, E. S. Moland, and K. S. Thomson. 2006. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-β-lactamase, IMP-18. Antimicrob. Agents Chemother. 50:2272-3. - PMC - PubMed
    1. Jones, R. N., C. Mendes, P. J. Turner, and R. Masterton. 2005. An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997-2004. Diagn. Microbiol. Infect. Dis. 53:247-56. - PubMed
    1. Lolans, K., A. M. Queenan, K. Bush, A. Sahud, and J. P. Quinn. 2005. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States. Antimicrob. Agents Chemother. 49:3538-40. - PMC - PubMed
    1. Sader, H. S., L. M. Deshpande, R. Morfin-Otero, U. Garza-Ramos, J. Silva-Sanchez, and R. N. Jones. 2007. Dissemination of IMP-type metallo-β-lactamases among Pseudomonas aeruginosa and emergence of VIM-2 in Klebsiella oxytoca in Mexico: report from the SENTRY Antimicrobial Surveillance Program, abstr. C2-2061, p. 150. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL.